Search Login Register

everolimus Summary

Description: a rapamycin analog; structure in first source

Also Known As: 40-O-(2-hydroxyethyl)-rapamycin; Certican; RAD 001; RAD001; SDZ RAD Show All >>

Networked: 1756 relevant articles (258 outcomes, 614 trials/studies) for this Drug

Key Diseases for which everolimus is Relevant

  1. Neoplasms (Cancer) : 49 outcomes 111 studies in 419 results
  2. Renal Cell Carcinoma (Grawitz Tumor) : 34 outcomes 65 studies in 212 results
  3. Breast Neoplasms (Breast Cancer) : 32 outcomes 75 studies in 166 results
  4. Neuroendocrine Tumors (Neuroendocrine Tumor) : 17 outcomes 45 studies in 85 results
  5. Primitive Neuroectodermal Tumors (PNET) : 13 outcomes 24 studies in 45 results
Show All >>

Drugs Related to everolimus

  1. Sirolimus (Rapamycin)
  2. sunitinib (Sutent)
  3. everolimus
  4. sorafenib (BAY 43-9006)
  5. temsirolimus
  6. exemestane (Aromasin)
  7. Hormones
  8. Octreotide (Sandostatin)
  9. Paclitaxel (Taxol)
  10. Protein-Tyrosine Kinases (Tyrosine Kinase)
Show All >>

Therapies Related to everolimus

  1. Stents
  2. Transplants (Transplant)
  3. Drug Therapy (Chemotherapy)
  4. Aftercare (After-Treatment)
  5. Heterologous Transplantation (Xenotransplantation)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.